Lv4
462 积分 2024-06-18 加入
Design and optimization strategies of PROTACs and its Application, Comparisons to other targeted protein degradation for multiple oncology therapies
6天前
已完结
Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design
6天前
已完结
Identification of Thiourea-Based Inhibitors of the B-Cell Lymphoma 6 BTB Domain via NMR-Based Fragment Screening and Computer-Aided Drug Design
6天前
已完结
Progress toward B-Cell Lymphoma 6 BTB Domain Inhibitors for the Treatment of Diffuse Large B-Cell Lymphoma and Beyond
6天前
已完结
Targeting BCL6 in Gastrointestinal Stromal Tumor Promotes p53-Mediated Apoptosis to Enhance the Antitumor Activity of Imatinib
6天前
已完结
BCL6 as a therapeutic target for lymphoma
6天前
已关闭
Pharmaceutical inhibition of BCL6 ameliorates resistance to imatinib in chronic myeloid leukemia
12天前
已关闭
BCL6 (B-cell lymphoma 6) expression in adenomyosis, leiomyomas and normal myometrium
12天前
已完结
The transcriptional modulator BCL6 as a molecular target for breast cancer therapy
12天前
已完结
BCL6 promotes glioma and serves as a therapeutic target
12天前
已完结
皖公网安备34019202002308
